Cargando…

Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma

Even though several SARS-CoV-2 vaccines have shown high effectiveness in the prevention of COVID-19 in healthy subjects, vaccination response in patients with plasma-cell-related disorders (PCD) remains widely unknown. Here, we report on an analysis describing the serological response after prime-bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghandili, Susanne, Schönlein, Martin, Wiessner, Christian, Becher, Heiko, Lütgehetmann, Marc, Brehm, Thomas Theo, Schulze zur Wiesch, Julian, Bokemeyer, Carsten, Sinn, Marianne, Weisel, Katja C., Leypoldt, Lisa B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658197/ https://www.ncbi.nlm.nih.gov/pubmed/34884200 http://dx.doi.org/10.3390/jcm10235499

Ejemplares similares

OAB-049: Poor post-vaccination anti-SARS-CoV-2-antibody response in patients with Multiple Myeloma correlates with low CD19+ B-lymphocyte count and anti-CD38 treatment
por: Ghandili, Susanne, et al.
Publicado: (2021)

CD19+ B Lymphocytes Are Predictive for Anti-Sars-Cov-2 Vaccination Response in Multiple Myeloma Patients
por: Ghandili, Susanne, et al.
Publicado: (2021)

Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment
por: Ghandili, Susanne, et al.
Publicado: (2021)

Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients—COVIDOUT study
por: Schönlein, Martin, et al.
Publicado: (2022)

VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience
por: Ghandili, Susanne, et al.
Publicado: (2022)

Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma
por: Brauneck, Franziska, et al.
Publicado: (2021)

Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis
por: Modemann, Franziska, et al.
Publicado: (2022)

Lower Levels of Transaminases but Higher Levels of Serum Creatinine in Patients with Acute Hepatitis E in Comparison to Patients with Hepatitis A
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Clinically HIV but negative serology: Think of idiopathic CD4(+) lymphocytopenia
por: Nagar, Vidya Sanjay, et al.
Publicado: (2016)

Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
por: Pflüger, Lisa Sophie, et al.
Publicado: (2020)

A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies
por: Ghandili, Susanne, et al.
Publicado: (2021)

COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress
por: Modemann, Franziska, et al.
Publicado: (2022)

Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

The Clinical Perspective on Hepatitis E
por: Horvatits, Thomas, et al.
Publicado: (2019)

Clinical features of hepatitis E infections in patients with hematologic disorders
por: Ghandili, Susanne, et al.
Publicado: (2022)

Lymphocytosis, Lymphocytopenia, Hypergammaglobulinemia, and Hypogammaglobulinemia
por: Mims, Martha P.
Publicado: (2018)

Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study
por: Woo, Marcel S., et al.
Publicado: (2022)

Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients
por: Brehm, Thomas Theo, et al.
Publicado: (2019)

Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19
por: Heide, Janna, et al.
Publicado: (2021)

Correction: Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19
por: Heide, Janna, et al.
Publicado: (2022)

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Idiopathic CD4 lymphocytopenia with sensorimotor polyneuropathy
por: Puri, Vinod, et al.
Publicado: (2016)

Idiopathic CD4 Lymphocytopenia: Current Insights
por: Vijayakumar, Saravanakumari, et al.
Publicado: (2020)

Erratum zu: Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
por: Ghandili, Susanne, et al.
Publicado: (2020)

Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic
por: Engelmann, Petra, et al.
Publicado: (2022)

Lymphocytopenia as an independent predictor of early recurrence in breast cancer.
por: Pattison, C. W., et al.
Publicado: (1987)

Lymphocytopenia exacerbated by lack of sleep caused by heavy workload
por: Nishizaki, Yuji, et al.
Publicado: (2017)

Idiopathic CD4(+) T-lymphocytopenia with bronchiectasis and hyperimmunoglobulin A
por: Kose, Mehmet, et al.
Publicado: (2008)

Idiopathic CD4+ T lymphocytopenia: A case report
por: Umamaheshwari, S, et al.
Publicado: (2020)

Lymphocytopenia and Radiotherapy Treatment Volumes in the Time of COVID-19
por: Joseph, N., et al.
Publicado: (2020)

Idiopathic CD4+T lymphocytopenia: A case report
por: Damara, FA, et al.
Publicado: (2020)

Importance of immunoglobulin therapy for COVID-19 patients with lymphocytopenia
por: Nabih, Heba K.
Publicado: (2021)

Idiopathic CD4 Lymphocytopenia Presenting as Cryptococcal Meningitis
por: Shah, Preet Mukesh, et al.
Publicado: (2021)

Longitudinal SARS-CoV-2 Seroprevalence among Employees in Outpatient Care Services in Hamburg
por: Schablon, Anja, et al.
Publicado: (2023)

Tecovirimat for the treatment of severe Mpox in Germany
por: Hermanussen, Lennart, et al.
Publicado: (2023)

56/m mit Rückenschmerzen und Konzentrationsstörungen: Vorbereitung auf die Facharztprüfung: Fall 4
por: Leypoldt, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fnplh4fn7mmioaq85t1rpfobob